Cervical Cancer Clinical Trials in Milan, Lombardy
3 recruitingMilan, Lombardy, Italy
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Cervical Cancer
Merck Sharp & Dohme LLC686 enrolled239 locationsNCT06459180
Recruiting
Phase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Merck Sharp & Dohme LLC1,023 enrolled60 locationsNCT07216703
Recruiting
Multimodality Treatments of HPV-related Lesions of the Female Genital Tract
Cervical CancerHPVCervix Lesion+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano200 enrolled1 locationNCT05938192